Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Glioblastoma 9Recurrence 1Oligodendroglioma 1Neoplasms 1Neoplasm Recurrence, Local 1Medulloblastoma 1Lymphoma, Large B-Cell, Diffuse 1Glioma 1Central Nervous System Neoplasms 1Burkitt Lymphoma 1Brain Neoplasms 1Astrocytoma 1

Interventions

Rituximab 41Cyclophosphamide 37Magnetic Resonance Spectroscopy 22Specimen Handling 20Prednisone 19Doxorubicin 19polatuzumab vedotin 18Lenalidomide 17Biopsy 15fludarabine 13Oxaliplatin 13Gemcitabine 13Vincristine 12zanubrutinib 11Immunotherapy, Adoptive 11Etoposide 10glofitamab 8obinutuzumab 7axicabtagene ciloleucel 7Prednisolone 7ibrutinib 6N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 6Leukapheresis 6Injections 6Ifosfamide 6CT-P10 6Bendamustine Hydrochloride 6orelabrutinib 5loncastuximab tesirine 5fludarabine phosphate 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Lymphoma, Large B-Cell, Diffuse × Lomustine × Clear all
NCT05518383 2022-08-26

B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Phase 4 Recruiting
300 enrolled
Lymphoid

Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡